Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulating apoptosis as a target for effective therapy.

Aarne Fleischer1, Ata Ghadiri, Frédéric Dessauge

  • 1Laboratoire d'Immunologie Cellulaire et Tissulaire, U543 INSERM, Hôpital Pitié Salpêtrière, Bâtiment CERVI, 83 Bd de 1'Hôpital, 75013 Paris, France.

Molecular Immunology
|August 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fermented bread, a promising additive to pig feed to improve intestinal health-an <i>in vitro</i> study.

PeerJ·2026
Same author

Identification of peptides interfering with the PP2Ac And LRRK2 interaction.

Biochimica et biophysica acta. Proteins and proteomics·2026
Same author

IPEC-J2 as a cellular model for studying intestinal mucus.

Scientific reports·2025
Same author

Comprehensive evaluation of a pea co-product for piglet nutrition: fibre content, protein digestion, and intestinal barrier function.

Journal of animal science·2025
Same author

Exploring the interaction between a LRRK2/PP1CA interfering peptide and PP1CA.

Journal of molecular graphics & modelling·2025
Same author

Evaluation of CD4<sup>+</sup> CD25<sup>+/high</sup> CD127<sup>low/-</sup> Regulatory T-Cells in Different Stages of Psoriatic Arthritis Patients.

Advanced biomedical research·2024
Same journal

m6A modification of LINC00458 enhances HMOX1 stability via ELAVL1 recruitment to promote ferroptosis and aggravate asthma.

Molecular immunology·2026
Same journal

Overexpression of Hes1 inhibits cigarette smoke-induced mitochondrial apoptosis in AT2 cells by activating the Pgc-1α/Tfam signaling pathway.

Molecular immunology·2026
Same journal

Progesterone promotes favorable pregnancy outcomes in recurrent spontaneous, abortion by attenuating NK Cell overactivation and upregulating the cAMP/PKA/CREB signaling axis.

Molecular immunology·2026
Same journal

Oleanolic acid alleviates hepatic fibrosis by inhibiting liver macrophage recruitment and polarization.

Molecular immunology·2026
Same journal

Cordycepin attenuates diabetic nephropathy by dual-pathway activation of TFEB to restore autophagy and ameliorate podocyte injury.

Molecular immunology·2026
Same journal

Endothelial-derived TWEAK drives granulosa cell apoptosis in PCOS via the Fn14-oxidative stress axis.

Molecular immunology·2026
See all related articles

Targeting cell proliferation and death pathways offers new therapeutic strategies for diseases like cancer and neurodegenerative disorders. Research focuses on apoptosis regulators and gene therapy for effective treatments.

Area of Science:

  • Molecular Biology
  • Pathogenesis
  • Therapeutics

Background:

  • Cell proliferation and death are critical in diseases like cancer, neurodegeneration, and autoimmune disorders.
  • Understanding molecular regulation of these processes enables targeted therapies.
  • Apoptosis (programmed cell death) is a key pathway for disease intervention.

Purpose of the Study:

  • To review molecular targets and therapeutic strategies for diseases involving altered cell proliferation and death.
  • To highlight advancements in targeting apoptosis for cancer, neurodegenerative, and autoimmune diseases.
  • To explore the potential of gene therapy in neurodegenerative disorders.

Main Methods:

  • Review of scientific literature on cell death and proliferation pathways.

Related Experiment Videos

  • Analysis of molecular targets including TNF, caspases, p53-MDM2, NF-kappaB, PI3K, Bcl-2 family, IAPs, STAT, and Par-4.
  • Examination of therapeutic approaches such as drug targeting, gene therapy, and immune modulation.

    • Main Results:

    • Targeting apoptosis regulators (e.g., Bcl-2 family, IAPs) shows promise in cancer therapy.
    • Interferon beta and STAT pathway modulation are used for autoimmune diseases.
    • Blocking Par-4 and caspase activation can prevent neuronal death in neurodegenerative models.
    • Gene therapy presents a potential treatment for neurodegenerative disorders.

    Conclusions:

    • Targeting cell death and proliferation pathways provides rational therapeutic strategies for various diseases.
    • Diverse molecular targets and approaches, including apoptosis modulation and gene therapy, are being explored.
    • Further research into these pathways can lead to more effective disease treatments.